CFS
GSK icon

Capital Financial Services’s GSK GSK Stock Holding History

Capital Financial Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,744
Closed -$212K – 66
2021
Q1 		$212K Buy
4,744
+160
+3% +$7.26K 0.28% 60
2020
Q4 		$211K Buy
+4,584
New +$211K 0.29% 59

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Capital Financial Services's GSK Position: Q2 2021 in Review

Capital Financial Services sold out of GSK (GSK) in Q2 2021, closing a stake of 4,744 shares — an estimated $212K sold.

Capital Financial Services first reported a position in GSK in Q4 2020 and held it in 2 quarters. The position peaked at $212K in Q1 2021. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

  • Capital Financial Services reported no remaining GSK position as of Q2 2021 after selling out during the quarter.
  • Capital Financial Services sold 4,744 GSK shares in Q2 2021, an estimated $212K.
  • Capital Financial Services first reported a position in GSK in Q4 2020 and held it in 2 quarters.
  • Capital Financial Services's GSK position peaked at $212K in Q1 2021.
  • 798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Capital Financial Services's 13F filing for Q2 2021, filed 28 Jul 2022.